Caliway Biopharmaceuticals
6919.TW
#3946
Rank
S$4.21 B
Marketcap
S$2.71
Share price
-2.71%
Change (1 day)
-49.29%
Change (1 year)

EPS for Caliway Biopharmaceuticals (6919.TW)

EPS in 2026 (TTM): S-$0.01589

According to Caliway Biopharmaceuticals's latest financial reports the company's current EPS (TTM) is S-$0.01598. In 2025 the company made an earnings per share (EPS) of S-$0.009489 an increase over its 2024 EPS that were of S-$0.01613.

EPS history for Caliway Biopharmaceuticals from 2019 to 2026

Annual EPS

Year EPS Change
2026 (TTM)S-$0.0158967.47%
2025S-$0.009489-41.18%
2024S-$0.01613-2.54%
2023S-$0.0165561.29%
2022S-$0.01026-54.79%
2021S-$0.02270167.71%
2020S-$0.008479-43.21%
2019S-$0.01493